Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

Published Date: 07 Jun 2024

Enhancing quality of life was another benefit of anticholinergic oxybutynin for ADT-using patients.

Read Full News

Latest News

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Latest News

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

News All Time

Study Linking Fruits, Veggies to Lung Cancer Raises Eyebrows

Association by way of pesticide exposure proposed, but outside experts not so sure

More Positive Survival Data in Lung Cancer With Perioperative Therapy

High rate of tumor DNA clearance with chemoimmunotherapy portends improved EFS, possibly OS

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Several justices seemed sympathetic to Monsanto's argument that it can't be sued under state law

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

News, features, and commentary about cancer-related issues

FDA Says First 'Real-Time' Clinical Trial Is Underway

Two sponsors are on board, with a larger pilot program planned later this year

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

However, rates were improved from previous survey results

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins in 93%

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

His death followed a hospitalization for cancer treatment side effects

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful"

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

News, features, and commentary about cancer-related issues

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Here's what two brain surgeries taught me about public health and care access

Why Did Rare Cancer Shrink on Its Own?

Case illustrates the mystery of spontaneous regression

Woman Loses 6-Year Battle With Mouth Tumor

Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

News, features, and commentary about cancer-related issues

Recommended News For You

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

New surgical method shows promising results for cervical cancer treatment

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Recommended Articles For You

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment 

Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management 

The Link Between Being Overweight and Cancer 

Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Which Risk Model Better Identifies High-Risk Smoldering MM?

2.

Study offers clearer picture of childhood brain tumor survival

3.

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

4.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

5.

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

1.

Exploring the Latest Treatments for Desmoid Tumors

2.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

3.

The Millionaire's Battle: Does Mark Cuban Have Cancer?

4.

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer

5.

Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot